DOI QR코드

DOI QR Code

Influence of Curcumin on HOTAIR-Mediated Migration of Human Renal Cell Carcinoma Cells

  • Pei, Chang-Song (The First Clinical Medical College, Nanjing University of Chinese Medicine) ;
  • Wu, Hong-Yan (Department of Pharmacy, Yancheng Health Vocational and Technical College) ;
  • Fan, Fan-Tian (School of Pharmaceutical Science, Nanjing University of Chinese Medicine) ;
  • Wu, Yi (Department of Urology, The Second Affiliated Hospital of Xuzhou Medical School) ;
  • Shen, Cun-Si (School of Pharmaceutical Science, Nanjing University of Chinese Medicine) ;
  • Pan, Li-Qun (The First Clinical Medical College, Nanjing University of Chinese Medicine)
  • Published : 2014.05.30

Abstract

Background: This study investigated the influence of curcumin on HOX transcript antisense RNA (HOTAIR)-mediated migration of cultured renal cell carcinoma (RCC) cells. Materials and Methods: Five RCC cell lines (769-P, 769-P-vector, 769-P-HOTAIR, 786-0, and Kert-3 ) were maintained in vitro. The expression of HOTAIR mRNA was determined by quantitative real-time PCR and cell migration was measured by transwell migration assay. The effects of different concentrations of curcumin (0 to $80{\mu}mol/L$) on cell proliferation was determined by the CCK-8 assay and influence of non-toxic levels (0 to $10{\mu}M$) on the migration of RCC cells was also determined. Results: Comparison of the 5 cell lines indicated a correlation between HOTAIR mRNA expression and cell migration. In particular, the migration of 769-P-HOTAIR cells was significantly higher than that of 769-P-vector cells. Curcumin at $2.5-10{\mu}M$ had no evident toxicity against RCC cells, but inhibited cell migration in a concentration-dependent manner. Conclusions: HOTAIR expression is correlated with the migration of RCC cells, and HOTAIR may be involved in the curcumin-induced inhibition of RCC metastasis.

Keywords

References

  1. Bae E, Calhoun VC, Levine M, et al (2002). Characterization of the intergenic RNA profile at abdominal-A and Abdominal-B in the Drosophila bithorax complex. Proc Natl Acad Sci USA, 99, 16847-52. https://doi.org/10.1073/pnas.222671299
  2. Balasubramanian S, Eckert RL (2007). Keratinocyte proliferation, differentiation, and apoptosis--differential mechanisms of regulation by curcumin, EGCG and apigenin. Toxicol Appl Pharmacol, 224, 214-9. https://doi.org/10.1016/j.taap.2007.03.020
  3. Bernstein BE, Kamal M, Lindblad-Toh K, et al (2005). Genomic maps and comparative analysis of histone modifications in human and mouse. Cell, 120, 169-81. https://doi.org/10.1016/j.cell.2005.01.001
  4. Boonrao M, Yodkeeree S, Ampasavate C, et al (2010). The inhibitory effect of turmeric curcuminoids on matrix metalloproteinase-3 secretion in human invasive breast carcinoma cells. Arch Pharm Res, 33, 989-98. https://doi.org/10.1007/s12272-010-0703-6
  5. Carninci P, Kasukawa T, Katayama S, et al (2005). The transcriptional landscape of the mammalian genome. Science, 309, 1559-63. https://doi.org/10.1126/science.1112014
  6. Chow WH, Devesa SS, Warren JL, Fraumeni JF, Jr. (1999). Rising incidence of renal cell cancer in the United States. JAMA, 281, 1628-31. https://doi.org/10.1001/jama.281.17.1628
  7. Drewell RA, Bae E, Burr J, Lewis EB (2002). Transcription defines the embryonic domains of cis-regulatory activity at the Drosophila bithorax complex. Proc Natl Acad Sci USA, 99, 16853-8. https://doi.org/10.1073/pnas.222671199
  8. Esteller M (2007). Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer, 96, 26-30.
  9. Ferlay J, Autier P, Boniol M, et al (2007). Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol, 18, 581-92.
  10. Ficarra V, Artibani W (2006). Staging system of renal cell carcinoma: current issues. Eur Urol, 49, 223-5. https://doi.org/10.1016/j.eururo.2005.11.018
  11. Guo LY, Cai XF, Lee JJ, et al (2008). Comparison of suppressive effects of demethoxycurcumin and bisdemethoxycurcumin on expressions of inflammatory mediators in vitro and in vivo. Arch Pharm Res, 31, 490-6. https://doi.org/10.1007/s12272-001-1183-8
  12. Gupta RA, Shah N, Wang KC, et al (2010). Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature, 464, 1071-6. https://doi.org/10.1038/nature08975
  13. Kern I, Rossier MF, Chappuis PO (2007). [Epigenetics and cancer]. Rev Med Suisse, 3, 540-2, 44-5.
  14. Kogo R, Shimamura T, Mimori K, et al (2011). Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res, 71, 6320-6. https://doi.org/10.1158/0008-5472.CAN-11-1021
  15. Lam JS, Klatte T, Breda A (2009). Staging of renal cell carcinoma: Current concepts. Indian J Urol, 25, 446-54. https://doi.org/10.4103/0970-1591.57906
  16. Mohan S, Mohanasenthil, Paul SF, et al (2009). Interleukin-4-receptor alpha gene polymorphism and the risk of renal cell carcinoma in a South Indian population. Asian Pac J Cancer Prev, 10, 295-8.
  17. Moskvina LV, Andreeva I, Mal'kov PG (2011). [Prognostic factors of renal cell carcinoma]. Arkh Patol, 73, 47-52.
  18. Rouviere O, Bouvier R, Negrier S, et al (2006). Nonmetastatic renal-cell carcinoma: is it really possible to define rational guidelines for post-treatment follow-up? Nat Clin Pract Oncol, 3, 200-13.
  19. Sessa L, Breiling A, Lavorgna G, et al (2007). Noncoding RNA synthesis and loss of Polycomb group repression accompanies the colinear activation of the human HOXA cluster. RNA, 13, 223-39.
  20. van Herpen CM, De Mulder PH (2002). Prognostic and predictive factors of immunotherapy in metastatic renal cell carcinoma. Crit Rev Oncol Hematol, 41, 327-34. https://doi.org/10.1016/S1040-8428(01)00173-1
  21. Volpe A, Patard JJ (2010). Prognostic factors in renal cell carcinoma. World J Urol, 28, 319-27. https://doi.org/10.1007/s00345-010-0540-8
  22. Yang Z, Zhou L, Wu LM, et al (2011). Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol, 18, 1243-50. https://doi.org/10.1245/s10434-011-1581-y
  23. Yap NY, Ng KL, Ong TA, et al (2013). Clinical prognostic factors and survival outcome in renal cell carcinoma patients--a Malaysian single centre perspective. Asian Pac J Cancer Prev, 14, 7497-500. https://doi.org/10.7314/APJCP.2013.14.12.7497
  24. Zhang CY, Zhang L, Yu HX, et al (2013). Curcumin inhibits invasion and metastasis in K1 papillary thyroid cancer cells. Food Chem, 139, 1021-8. https://doi.org/10.1016/j.foodchem.2013.02.016
  25. Zhang J, Zhang P, Wang L, et al (2014). Long non-coding RNA HOTAIR in carcinogenesis and metastasis. Acta Biochim Biophys Sin (Shanghai), 46, 1-5. https://doi.org/10.1093/abbs/gmt117
  26. Zhao J, Zhao Y, Zheng W, et al (2008). Neuroprotective effect of curcumin on transient focal cerebral ischemia in rats. Brain Res, 1229, 224-32. https://doi.org/10.1016/j.brainres.2008.06.117

Cited by

  1. Functional Roles of Long Non-coding RNA in Human Breast Cancer vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.5993
  2. Long non-coding RNA: A new paradigm for lung cancer vol.54, pp.11, 2015, https://doi.org/10.1002/mc.22362
  3. Identification of differentially expressed signatures of long non-coding RNAs associated with different metastatic potentials in gastric cancer vol.51, pp.2, 2016, https://doi.org/10.1007/s00535-015-1091-y
  4. Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells vol.12, pp.1, 2017, https://doi.org/10.1371/journal.pone.0170860
  5. Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma vol.18, pp.8, 2017, https://doi.org/10.3390/ijms18081774
  6. Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma vol.17, pp.4, 2016, https://doi.org/10.3390/ijms17040573
  7. The Role of Compounds Derived from Natural Supplement as Anticancer Agents in Renal Cell Carcinoma: A Review vol.19, pp.1, 2018, https://doi.org/10.3390/ijms19010107
  8. Identification of lncRNA EGOT as a tumor suppressor in renal cell carcinoma vol.16, pp.5, 2017, https://doi.org/10.3892/mmr.2017.7470
  9. Curcumin as a therapeutic agent in leukemia pp.00219541, 2019, https://doi.org/10.1002/jcp.28072